Erik Anders Kronström
Geschäftsführer bei INFANT BACTERIAL THERAPEUTICS AB
Vermögen: 89 953 $ am 30.04.2024
Aktive Positionen von Erik Anders Kronström
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INFANT BACTERIAL THERAPEUTICS AB | Geschäftsführer | 01.01.2018 | - |
Technik-/Wissenschafts-/F&E-Leiter | 20.10.2014 | 01.01.2018 |
Karriereverlauf von Erik Anders Kronström
Ehemalige bekannte Positionen von Erik Anders Kronström
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Vorstandsvorsitzender | - | - |
Ausbildung von Erik Anders Kronström
Royal Institute of Technology | Graduate Degree |
Warwick Business School | Masters Business Admin |
Statistik
International
Schweden | 3 |
Norwegen | 2 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 1 |
Graduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
Private Unternehmen | 1 |
---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
- Börse
- Insiders
- Erik Anders Kronström
- Erfahrung